Search

everythinglearnresearchcommunity

for

Search:↓

Gingivitis may increase a hormone linked to ovarian function in women with a certain ovary condition, and treating gum disease could help manage it.

Early diagnosis and personalized treatment are crucial for managing pediatric androgenetic alopecia.

Lifestyle changes like a healthy diet, exercise, and proper sleep can help manage PCOD.

PCOS may increase the risk of certain cancers.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Higher fasting insulin levels increase the risk of androgenetic alopecia.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Kids from areas with more high school dropouts have higher rates of brain injuries.

Increasing Teneligliptin on his own caused a man's hair loss, which stopped when he ceased the medication.

An elderly woman with cancer improved after treatment for a rare skin condition with coiled hairs.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Obesity is common in PCOS patients and early treatment is important for their heart and metabolic health.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

More research is needed to understand the long-term benefits of insulin-sensitizing drugs for treating adolescents with PCOS.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

A woman's increased facial hair and hair loss were caused by a rare ovarian tumor, cured by surgery.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Androgenetic alopecia is more common in Saudi men than women.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Glucocorticoids can cause various health issues, but some treatments may help reduce these effects.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.